Naor Nir has filed 4 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 180000 shares of BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Naor Nir | Director | A | Stock Option (Right to Buy) | 180000 | $0.70 | 180,000.0000 | 9,268,976 | 9999.99% | 1.94% |
| Jan. 6, 2025 | Axogen, Inc. | $AXGN | Naor Nir | CFO | F | Common Stock | 39132 | $15.22 | 260,868.0000 | 44,257,754 | 13.04% | 0.09% |
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Naor Nir | Director | A | Common Stock | 30666 | $0.00 | 31,465.0000 | 5,021,798 | 3838.05% | 0.61% |
| Jan. 1, 2024 | Axogen, Inc. | $AXGN | Naor Nir | CFO | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 42,878,543 | 9999.99% | 0.70% |